Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Sizing Up the CDMO Market

A new analysis highlights growth drivers and challenges for clinical supply-chain services.
Nov 10, 2009

A new analysis highlights growth drivers and challenges for clinical supply-chain services.

Facing Reality

Contract organizations waiting for the pipeline to come roaring back are kidding themselves.
Nov 2, 2009

Contract organizations waiting for the pipeline to come roaring back are kidding themselves.

Reality not insanity

CDMOs waiting for the pipeline to come roaring back are kidding themselves.
Nov 1, 2009

Apopular definition of insanity is repeating the same task over and over again while expecting a different result. It would appear, therefore, that many people in the contract services industry think the major global bio/pharma companies are insane.

Expansion Plan

Contract-service providers are expanding their offerings in this slow-growth environment.
Oct 9, 2009

Contract-service providers are expanding their offerings in this slow-growth environment.

Sizing Up the CDMO Market

A new analysis highlights growth drivers and challenges for clinical supply-chain services.
Oct 2, 2009

A new analysis highlights growth drivers and challenges for clinical supply-chain services.

Expansion Plan

Contract-service providers are expanding their offerings in this slow-growth environment.
Sep 2, 2009

Contract-service providers are expanding their offerings in this slow-growth environment.

Step Carefully into Foreign Affairs

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.
Sep 1, 2009

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.

Expansion plan

Sep 1, 2009

In the current slow growth environment, service providers are looking to tactical expansions, as well as more ambitious strategic service expansions.

Step Carefully into Foreign Affairs

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.
Aug 2, 2009

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
29%
Attracting a skilled workforce
26%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here